Institutional Ownership Monte Rosa Therapeutics, Inc. (GLUE)
This table provides information about the institutional ownership of Monte Rosa Therapeutics, Inc. (GLUE). We have compiled data on the 107 institutions that hold shares in the stock, with a total of 53.8 Million shares, which have been reported (via 13F filing form) to have a value of $356 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Nea Management Company, LLC
Timonium, MD |
Feb 14, 2025 Q4 2024 |
7,692,298
shares
|
$51 Million
3.81% of portfolio
|
Q4 2022
Reduced 0.14%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
7,116,637
shares
|
$47.2 Million
0.01% of portfolio
|
Q4 2024
Added 7.81%
|
|
|
Versant Venture Management, LLC
San Francisco, CA |
Feb 11, 2025 Q4 2024 |
5,652,922
shares
|
$37.5 Million
58.01% of portfolio
|
Q4 2024
New holding
|
|
|
Baker Bros. Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
4,916,095
shares
|
$32.6 Million
0.38% of portfolio
|
Q3 2023
Added 62.57%
|
|
|
Avoro Capital Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
4,345,000
shares
|
$28.8 Million
0.44% of portfolio
|
Q4 2024
Reduced 24.96%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
3,156,354
shares
|
$20.9 Million
0.0% of portfolio
|
Q4 2024
Added 24.55%
|
|
|
Bvf Inc
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
2,764,471
shares
|
$18.3 Million
0.72% of portfolio
|
Q4 2024
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,360,093
shares
|
$15.6 Million
0.0% of portfolio
|
Q2 2024
Added 2.3%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
2,255,353
shares
|
$15 Million
0.0% of portfolio
|
Q4 2024
Added 1699.5%
|
|
|
Suvretta Capital Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,563,798
shares
|
$10.4 Million
0.45% of portfolio
|
Q4 2024
Reduced 41.19%
|
|
|
Aisling Capital Management LP
New York, NY |
Feb 12, 2025 Q4 2024 |
1,472,331
shares
|
$9.76 Million
3.74% of portfolio
|
Q2 2021
New holding
|
|
|
Alphabet Inc.
Mountain View, CA |
Feb 06, 2025 Q4 2024 |
1,464,015
shares
|
$9.71 Million
0.72% of portfolio
|
Q2 2021
New holding
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,076,430
shares
|
$7.14 Million
0.0% of portfolio
|
Q4 2024
Added 56.55%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,036,665
shares
|
$6.87 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.77%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
778,386
shares
|
$5.16 Million
0.0% of portfolio
|
Q4 2024
Reduced 32.84%
|
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
499,492
shares
|
$3.31 Million
0.0% of portfolio
|
Q4 2024
Added 187.31%
|
|
|
Norges Bank
Oslo, Q8 |
Feb 12, 2025 Q4 2024 |
445,868
shares
|
$2.96 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Vestal Point Capital, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
425,000
shares
|
$2.82 Million
0.17% of portfolio
|
Q4 2024
Reduced 54.3%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
376,964
shares
|
$2.5 Million
0.0% of portfolio
|
Q4 2024
Added 5.13%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
370,472
shares
|
$2.46 Million
0.0% of portfolio
|
Q4 2024
Added 6.92%
|
|
|
Parkwood LLC
Cleveland, OH |
Feb 13, 2025 Q4 2024 |
323,000
shares
|
$2.14 Million
0.25% of portfolio
|
Q4 2024
Reduced 24.29%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Feb 14, 2025 Q4 2024 |
311,575
shares
|
$2.07 Million
0.36% of portfolio
|
Q4 2024
Reduced 0.01%
|
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
278,785
shares
|
$1.85 Million
0.0% of portfolio
|
Q4 2024
Added 1965.07%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
245,700
shares
|
$1.63 Million
0.0% of portfolio
|
Q4 2024
Added 12.35%
|
|
|
Wellington Management Group LLP
Boston, MA |
Feb 12, 2025 Q4 2024 |
221,741
shares
|
$1.47 Million
0.0% of portfolio
|
Q4 2024
Added 2.18%
|